Camlin Fine Sciences
Chemicals
CAMLINFINE NSE
₹74.15 −17.23 (−18.86%)
- P/E
- 255.69
Close 4 Nov 2026 ₹74.15 −115.16 −60.8% 1Y
Start ₹189.31
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 4.78%
- Debt to Equity
- 0.69
- EPS (TTM)
- ₹0.29
- Book Value
- ₹54.01
- Market Cap
- —
- P/E (TTM)
- 255.69
- P/B
- 1.37
- ROE
- 3.75%
- Dividend Yield
- 0.00%
- EBITDA
- ₹136 Cr
- 52W High
- ₹197.74
- 52W Low
- ₹73.25
- Day Range
- ₹73.25 – ₹85.28
- Volume
- 68,10,598
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Camlin Fine Sciences (this company) | ₹74.15 | 255.69 | ₹1,552 Cr | 1.37 | 0.00% | 3.75% | 4.78% | ₹1,845 Cr | ₹0 Cr |
| Median 8 companies | ₹1,559.55 | 57.54 | ₹20,474 Cr | 4.68 | 0.16% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
30 Poor
Data confidence 98/100
Category scores
- Quality
- 31
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 26
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 47
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 22
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 4
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 39
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company's working capital requirements have reduced from 35.3 days to 22.6 days
Weaknesses
4- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.74% over past five years.
- Company has a low return on equity of -6.99% over last 3 years.
- Earnings include an other income of Rs.63.6 Cr.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 4 | 4 |
| Oscillators | Bullish | 1 | 4 | 4 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Bearish
1
Neutral
4
Bullish
4
Overall
Strong Bearish
Bearish
11
Neutral
4
Bullish
4
Moving Averages
Strong Bearish
Bearish
10
Neutral
0
Bullish
0
Key readings
- RSI (14)
- 32.85
- Neutral
- MACD (12,26,9)
- −3.71
- Bullish
- SMA (50)
- 94.76
- Bearish
- SMA (200)
- 121.03
- Bearish
As of
Analyst Rating
Based on 2 analysts
1 of 2 analysts rate Buy, 1 Hold, 0 Sell.
As of
BUY
1
50% HOLD
1
50% SELL
0
0% Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +13.42% |
|---|---|
| 5Y | +7.74% |
| 3Y | +0.81% |
| 1Y | +5.77% |
| TTM | +9.36% |
Net profit
| 10Y | −3.97% |
|---|---|
| 5Y | −18.07% |
| 3Y | −15.66% |
| 1Y | Turned to profit |
| TTM | Loss narrowed by ₹134 Cr |
Operating cash flow
| 10Y | +1.31% |
|---|---|
| 5Y | −6.86% |
| 3Y | +17.15% |
| 1Y | +256.52% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −11.96 pp |
|---|---|
| 5Y | −8.90 pp |
| 3Y | −5.69 pp |
| 1Y | −7.08 pp |
| TTM | −6.71 pp |
Revenue by year
| Mar 2017 | ₹534 Cr |
|---|---|
| Mar 2018 | ₹721 Cr |
| Mar 2019 | ₹892 Cr |
| Mar 2020 | ₹1,049 Cr |
| Mar 2021 | ₹1,187 Cr |
| Mar 2022 | ₹1,412 Cr |
| Mar 2023 | ₹1,682 Cr |
| Mar 2024 | ₹1,454 Cr |
| Mar 2025 | ₹1,629 Cr |
| Mar 2026 | ₹1,723 Cr |
Net profit by year
| Mar 2017 | −₹4.00 Cr |
|---|---|
| Mar 2018 | −₹24.00 Cr |
| Mar 2019 | ₹3.00 Cr |
| Mar 2020 | ₹30.00 Cr |
| Mar 2021 | ₹65.00 Cr |
| Mar 2022 | ₹60.00 Cr |
| Mar 2023 | ₹40.00 Cr |
| Mar 2024 | −₹105 Cr |
| Mar 2025 | −₹158 Cr |
| Mar 2026 | ₹24.00 Cr |
Analyst Forecasts
Forecast For
FY27 consensus · EBITDA
₹252 Cr +85.5% vs FY26
Reported High Mean Low
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 420 | 406 | 386 | 377 | 381 | 417 | 431 | 432 | 408 | 460 | 441 | 425 | 520 | 491 |
| Expenses | 381 | 381 | 363 | 345 | 352 | 366 | 375 | 370 | 387 | 427 | 420 | 404 | 511 | 489 |
| Operating Profit | 39 | 25 | 23 | 31 | 29 | 52 | 56 | 62 | 20 | 33 | 21 | 21 | 9 | — |
| OPM % | 9% | 6% | 6% | 8% | 8% | 12% | 13% | 14% | 5% | 7% | 4.7% | 5% | 1.8% | — |
| Other Income | 6 | 2 | 2 | −96 | −15 | −151 | −8 | −22 | 0 | −4 | −24 | 103 | −10 | — |
| Interest | 10 | 20 | 14 | 16 | 23 | 26 | 34 | 15 | 15 | 19 | 17 | 23 | 14 | 21 |
| Depreciation | 19 | 19 | 21 | 13 | 15 | 17 | 14 | 17 | 16 | 19 | 16 | 21 | 19 | 20 |
| PBT | 16 | −12 | −10 | −94 | −23 | −143 | 0 | 8 | −11 | −9 | −37 | 80 | −34 | −37 |
| Tax % | 25% | 72% | 47% | −13% | 48% | −18% | 2164% | 98% | 0% | 65% | 0% | −8% | −1% | −19% |
| Net Profit | 12 | −21 | −14 | −82 | −35 | −116 | −7 | 0 | −11 | −15 | −37 | 86 | −34 | −30 |
| EPS (₹) | 0.83 | −1.03 | −0.63 | −4.11 | −1.81 | −5.33 | −0.22 | −0.04 | −0.53 | −0.76 | −1.89 | 4.59 | −1.65 | — |
Sep 2026: from the results filed on 3 Nov 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 558 | 489 | 534 | 721 | 892 | 1,049 | 1,187 | 1,412 | 1,682 | 1,454 | 1,629 | 1,723 | 1,845 |
| Expenses | 474 | 397 | 502 | 705 | 819 | 914 | 1,000 | 1,254 | 1,471 | 1,284 | 1,402 | 1,605 | 1,761 |
| Operating Profit | 84 | 92 | 32 | 16 | 73 | 135 | 187 | 158 | 211 | 170 | 227 | 118 | 84 |
| OPM % | 15% | 19% | 6% | 2.2% | 8% | 13% | 16% | 11% | 13% | 12% | 14% | 7% | 4.6% |
| Other Income | 9 | −1 | 14 | 12 | 14 | 3 | 5 | 33 | −4 | −142 | −218 | 59 | 64 |
| Interest | 24 | 24 | 31 | 32 | 41 | 48 | 42 | 41 | 64 | 70 | 107 | 83 | 73 |
| Depreciation | 16 | 17 | 22 | 27 | 29 | 33 | 44 | 56 | 63 | 56 | 61 | 71 | 75 |
| PBT | 53 | 50 | −6 | −31 | 17 | 58 | 105 | 94 | 80 | −99 | −159 | 23 | 0 |
| Tax % | −4% | 28% | −26% | −22% | 82% | 49% | 38% | 36% | 50% | 6% | 0% | −2% | — |
| Net Profit | 55 | 36 | −4 | −24 | 3 | 30 | 65 | 60 | 40 | −105 | −158 | 24 | 1 |
| EPS (₹) | 5.11 | 3.3 | −0.96 | −2.18 | 0.04 | 2.23 | 3.56 | 3.45 | 2.96 | −4.94 | −7.4 | 1.44 | 0.29 |
| Div. Payout % | 8% | 12% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 12 | 12 | 12 | 13 | 16 | 16 | 17 | 19 | 19 |
| Reserves | 125 | 167 | 202 | 359 | 359 | 391 | 631 | 732 | 804 | 848 | 883 | 1,022 |
| Borrowings | 160 | 180 | 331 | 373 | 461 | 539 | 550 | 646 | 801 | 683 | 652 | 720 |
| Other Liabilities | 131 | 123 | 126 | 273 | 255 | 290 | 282 | 396 | 425 | 424 | 467 | 559 |
| Total Liabilities | 426 | 479 | 669 | 1,016 | 1,087 | 1,232 | 1,475 | 1,790 | 2,045 | 1,972 | 2,020 | 2,320 |
| Fixed Assets | 106 | 140 | 201 | 278 | 272 | 306 | 584 | 601 | 858 | 816 | 704 | 887 |
| CWIP | 3 | 25 | 8 | 14 | 59 | 179 | 24 | 215 | 43 | 46 | 10 | 33 |
| Investments | 1 | 1 | 19 | 115 | 11 | 7 | 7 | 7 | 8 | 8 | 61 | 30 |
| Other Assets | 316 | 313 | 442 | 609 | 745 | 740 | 861 | 966 | 1,136 | 1,102 | 1,246 | 1,370 |
| Total Assets | 426 | 479 | 669 | 1,016 | 1,087 | 1,232 | 1,475 | 1,790 | 2,045 | 1,972 | 2,020 | 2,320 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 46 | 72 | −9 | −15 | −9 | 86 | 117 | 145 | 51 | 139 | 23 | 82 |
| Investing | −26 | −66 | −70 | −149 | −2 | −90 | −133 | −249 | −125 | −66 | −75 | −53 |
| Financing | −15 | −7 | 91 | 182 | 26 | 3 | 39 | 136 | 60 | −86 | 76 | −25 |
| Net Cash Flow | 4 | −1 | 13 | 18 | 15 | −1 | 23 | 32 | −14 | −13 | 24 | 4 |
| Free Cash Flow | 19 | 5 | −39 | −34 | −78 | −48 | 34 | −68 | −93 | 79 | −19 | 20 |
| CFO/EBITDA | 68 | 91 | 5 | −33 | 10 | 77 | 82 | 111 | 34 | 110 | 27 | 90 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 56 | 99 | 104 | 86 | 88 | 83 | 77 | 66 | 72 | 74 | 79 |
| Inventory Days | 184 | 311 | 277 | 207 | 219 | 204 | 200 | 178 | 255 | 256 | 234 | 199 |
| Days Payable | 144 | 171 | 110 | 154 | 127 | 119 | 99 | 112 | 129 | 154 | 180 | 200 |
| Cash Conversion Cycle | 114 | 196 | 266 | 157 | 178 | 173 | 184 | 143 | 192 | 174 | 127 | 78 |
| Working Capital Days | 12 | 1 | −6 | 19 | 43 | 22 | 55 | 40 | 42 | 51 | 33 | 23 |
| ROCE % | 28% | 24% | 5% | 0% | 7% | 11% | 13% | 10% | 10% | 8% | 12% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Camlin Fine Sciences insights
68 extracted metrics across FY08–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · May 2026Transcript PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT
- Q1 FY26 concall · Aug 2025Transcript PPT
- 26 May 2026
- 10 Nov 2025
- 10 Oct 2024
- 27 Sep 2023
- 22 Sep 2023
- 5 Aug 2022
- 6 Jul 2021
- General announcements 30 Oct 2026
Frequently Asked Questions about Camlin Fine Sciences
What does Camlin Fine Sciences Ltd do?
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
Where is Camlin Fine Sciences Ltd (CAMLINFINE) listed?
Camlin Fine Sciences Ltd trades as CAMLINFINE on the NSE and under code 532834 on the BSE.
Which sector does Camlin Fine Sciences Ltd belong to?
Camlin Fine Sciences Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd trades at a PE ratio of 255.69 as of 4 Nov 2026, on earnings per share of ₹0.29, against a book value of ₹54.01 per share.
What is the 52-week high and low of Camlin Fine Sciences Ltd?
Over the last 52 weeks Camlin Fine Sciences Ltd has traded between ₹73.25 and ₹197.74 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd reported a return on equity of 3.75%. Its debt-to-equity ratio is 0.69.
Company Information
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CAMLINFINE.md for Camlin Fine Sciences Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.